Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 36Neoplasms 32Prostatic Neoplasms 26Colorectal Neoplasms 25Lung Neoplasms 21Carcinoma, Non-Small-Cell Lung 16Hematologic Neoplasms 13Neoplasm Metastasis 10Pancreatic Neoplasms 9Ovarian Neoplasms 8Multiple Myeloma 8Head and Neck Neoplasms 8Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Hematopoietic and Lymphatic System Neoplasm 7Stomach Neoplasms 6Carcinoma, Renal Cell 6Anatomic Stage I Breast Cancer AJCC v8 6Uterine Cervical Neoplasms 5Sarcoma 5Glioma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Mouth Neoplasms 4Motor Activity 4Melanoma 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Carcinoma 4Gastrointestinal Neoplasms 4

Interventions

pembrolizumab 16Nivolumab 15Ipilimumab 12cemiplimab 10aldesleukin 6Interleukin-2 6Cyclophosphamide 6fludarabine 5fludarabine phosphate 4encorafenib 4binimetinib 4Blood Specimen Collection 4avelumab 3Sirolimus 3trametinib 2spartalizumab 2lifileucel 2dabrafenib 2atezolizumab 2Vemurafenib 2Surgical Procedures, Operative 2Specimen Handling 2Radiotherapy 2Prednisone 2Niacinamide 2Exercise 2Everolimus 2Dermoscopy 2Biopsy 2urelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Standard of Care × 1 year × Clear all
NCT06585410 2026-04-22

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Regeneron Pharmaceuticals

Phase 3 Recruiting
369 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡